| Literature DB >> 31419576 |
Si-Nan Sun1, Shuang Hu2, Yu-Ping Shang3, Liang-Yun Li2, Hong Zhou2, Jia-Si Chen2, Jun-Fa Yang2, Jun Li2, Qiang Huang4, Chuan-Pu Shen5, Tao Xu6.
Abstract
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally responsible for regulating >70% of human genes. MicroRNA-708 (miR-708) is encoded in the intron 1 of the Odd Oz/ten-m homolog 4 (ODZ4) gene. Numerous researches have confirmed that the abnormal expressed miR-708 is involved in the regulation of multiple types of cancer. Notably, the expression level of miR-708 was higher in lung cancer, bladder cancer (BC) and colorectal cancer (CRC) cell lines while lower in hepatocellular carcinoma (HCC), prostate cancer (PC), gastric cancer (GC) and so on. This review provides a current view on the association between miR-708 and several cancers and focuses on the recent studies of miR-708 regulation, discussing its potential as an epigenetic biomarker and therapeutic target for these cancers. In particular, the regulated mechanisms and clinical application of miR-708 in these cancers are also discussed.Entities:
Keywords: Cancer; Clinical application; MicroRNA; MicroRNA-708
Mesh:
Substances:
Year: 2019 PMID: 31419576 DOI: 10.1016/j.cellsig.2019.109390
Source DB: PubMed Journal: Cell Signal ISSN: 0898-6568 Impact factor: 4.315